Standout Papers

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced... 2010 2026 2015 2020 491
  1. Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205 (2010)
    Philip A. Philip, Jacqueline Benedetti et al. Journal of Clinical Oncology

Immediate Impact

6 by Nobel laureates 2 from Science/Nature 65 standout
Sub-graph 1 of 19

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
7 intermediate papers

Works of Saul E. Rivkin being referenced

Randomized, Placebo-Controlled Study of Oregovomab for Consolidation of Clinical Remission in Patients With Advanced Ovarian Cancer
2004
Dose response evaluation of adriamycin in human neoplasia
1977

Author Peers

Author Last Decade Papers Cites
Saul E. Rivkin 3531 1983 1101 126 5.7k
D. Spooner 3759 3353 1114 110 6.3k
P Dombernowsky 4290 2042 1233 194 6.6k
Pierre Kerbrat 4514 2071 1869 187 8.1k
F. Bonichon 3435 3316 1374 100 6.3k
Heather Lin 2096 1549 979 172 4.8k
Martin Harris 2452 1699 822 138 5.9k
Gian Luca De Salvo 1620 1424 885 135 4.2k
Philippe A. Cassier 3831 3092 1026 286 7.1k
Paul S. Ritch 2874 1640 703 133 4.5k
Andrés Poveda 2304 2139 583 154 5.6k

All Works

Loading papers...

Rankless by CCL
2026